DALIPAL HLDG (01921) spent 2.5427 million Hong Kong dollars to repurchase 852,000 shares on June 16.
Daliq Holdings (01921) announced that the company repurchased 852,000 shares on June 16, 2026, at a total cost of 2.527 million Hong Kong dollars. The repurchase price per share ranged from 2.95 to 3.08 Hong Kong dollars.
DALIPAL HLDG (01921) announced that the company repurchased 852,000 shares on June 16, 2026, at a total cost of HKD 2.5427 million. The repurchase price ranged from HKD 2.95 to 3.08 per share.
Related Articles
CSPC PHARMA (01093): The application for the listing permit of Valsartan and Amlodipine Maleate Tablets (SYH 9056 Tablets) has been accepted by the National Medical Products Administration.
REGENT PACIFIC(00575): Senstend receives a milestone approval from the National Medical Products Administration.
BEAUTYFARM MED (02373) spent 1.07 million Hong Kong dollars to repurchase 60,000 shares on June 16th.
CSPC PHARMA (01093): The application for the listing permit of Valsartan and Amlodipine Maleate Tablets (SYH 9056 Tablets) has been accepted by the National Medical Products Administration.
REGENT PACIFIC(00575): Senstend receives a milestone approval from the National Medical Products Administration.
BEAUTYFARM MED (02373) spent 1.07 million Hong Kong dollars to repurchase 60,000 shares on June 16th.
RECOMMEND
